ERBB2 and breast cancer: Using the hormone receptor status information, BC cases were stratified into the four principal molecular subtypes: luminal A (ER+, PR+, HER2−), luminal B (ER+, PR+, HER2+), HER2+ (ER−, PR−, HER2+), and triple negative (ER−, PR−, HER2−).